» Articles » PMID: 19706769

Identification of a Protein, G0S2, That Lacks Bcl-2 Homology Domains and Interacts with and Antagonizes Bcl-2

Overview
Journal Cancer Res
Specialty Oncology
Date 2009 Aug 27
PMID 19706769
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

The Bcl-2 family of proteins consists of both antiapoptotic and proapoptotic factors, which share sequence homology within conserved regions known as Bcl-2 homology domains. Interactions between Bcl-2 family members, as well as with other proteins, regulate apoptosis through control of mitochondrial membrane permeability and release of cytochrome c. Here we identify a novel regulator of apoptosis that lacks Bcl-2 homology domains but acts by binding Bcl-2 and modulating its antiapoptotic activity. To identify regulators of apoptosis, we performed expression profiling in human primary fibroblasts treated with tumor necrosis factor-alpha (TNF-alpha), a potent inflammatory cytokine that can regulate apoptosis and functions, at least in part, by inducing expression of specific genes through NF-kappaB. We found that the gene undergoing maximal transcriptional induction following TNF-alpha treatment was G(0)-G(1) switch gene 2 (G0S2), the activation of which also required NF-kappaB. We show that G0S2 encodes a mitochondrial protein that specifically interacts with Bcl-2 and promotes apoptosis by preventing the formation of protective Bcl-2/Bax heterodimers. We further show that ectopic expression of G0S2 induces apoptosis in diverse human cancer cell lines in which endogenous G0S2 is normally epigenetically silenced. Our results reveal a novel proapoptotic factor that is induced by TNF-alpha through NF-kappaB and that interacts with and antagonizes Bcl-2.

Citing Articles

Integrated lipidomics and RNA-seq reveal prognostic biomarkers in well-differentiated and dedifferentiated retroperitoneal liposarcoma.

Wang X, Ye J, Wu Y, Zhang H, Li C, Liu B Cancer Cell Int. 2024; 24(1):404.

PMID: 39696292 PMC: 11657886. DOI: 10.1186/s12935-024-03585-x.


Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics.

Akula S, Alvarado-Vazquez A, Haide Mendez Enriquez E, Bal G, Franke K, Wernersson S Int J Mol Sci. 2024; 25(23).

PMID: 39684762 PMC: 11642334. DOI: 10.3390/ijms252313050.


HSF1 is required for cellular adaptation to daily temperature fluctuations.

Takii R, Fujimoto M, Pandey A, Jaiswal K, Shearwin-Whyatt L, Grutzner F Sci Rep. 2024; 14(1):21361.

PMID: 39266731 PMC: 11393418. DOI: 10.1038/s41598-024-72415-x.


GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma.

Shen N, Luo M, Gu W, Gong M, Lei H, Bi L Oncogene. 2024; 43(33):2504-2516.

PMID: 38969770 DOI: 10.1038/s41388-024-03096-z.


Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils.

Shantaram D, Hoyd R, Blaszczak A, Antwi L, Jalilvand A, Wright V Nat Commun. 2024; 15(1):5434.

PMID: 38937454 PMC: 11211470. DOI: 10.1038/s41467-024-48935-5.


References
1.
Cacciapaglia F, Spadaccio C, Chello M, Gigante A, Coccia R, Afeltra A . Apoptotic molecular mechanisms implicated in autoimmune diseases. Eur Rev Med Pharmacol Sci. 2009; 13(1):23-40. View

2.
Beg A, Baltimore D . An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 1996; 274(5288):782-4. DOI: 10.1126/science.274.5288.782. View

3.
Bacchetti S, Graham F . Inhibition of cell-proliferation by an adenovirus vector expressing the human wild type-p53 protein. Int J Oncol. 2011; 3(5):781-8. DOI: 10.3892/ijo.3.5.781. View

4.
Adams J, Cory S . The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007; 26(9):1324-37. PMC: 2930981. DOI: 10.1038/sj.onc.1210220. View

5.
Chen C, Edelstein L, Gelinas C . The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol. 2000; 20(8):2687-95. PMC: 85484. DOI: 10.1128/MCB.20.8.2687-2695.2000. View